Nasdaq:US$14.14 (+0.48) | HKEX:HK$22.40 (+0.20) | AIM:£2.30 (+0)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 6 Apr 2011

AACR 2011: Savolitinib (HMPL-504) against subcutaneous xenograft and orthotopic brain tumor models